83 related articles for article (PubMed ID: 8865874)
1. Cytotoxicity, pH, and glucose degradation products in four different brands of PD fluid.
Wieslander A; Forsbäck G; Svensson E; Lindén T
Adv Perit Dial; 1996; 12():57-60. PubMed ID: 8865874
[TBL] [Abstract][Full Text] [Related]
2. Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro?
Wieslander AP; Andrén AH; Nilsson-Thorell C; Muscalu N; Kjellstrand PT; Rippe B
Perit Dial Int; 1995; 15(8):348-52. PubMed ID: 8785233
[TBL] [Abstract][Full Text] [Related]
3. Toxicity of effluent peritoneal dialysis fluid.
Wieslander AP; Andrén A; Martinson E; Kjellstrand P; Hultqvist M
Adv Perit Dial; 1993; 9():31-5. PubMed ID: 8105952
[TBL] [Abstract][Full Text] [Related]
4. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis.
Wieslander AP; Deppisch R; Svensson E; Forsbäck G; Speidel R; Rippe B
Perit Dial Int; 1995; 15(2):158-64. PubMed ID: 7612737
[TBL] [Abstract][Full Text] [Related]
5. Degradation in peritoneal dialysis fluids may be avoided by using low pH and high glucose concentration.
Kjellstrand P; Martinson E; Wieslander A; Kjellstrand K; Jeppsson E; Svensson E; Järkelid L; Linden T; Olsson LF
Perit Dial Int; 2001; 21(4):338-44. PubMed ID: 11587395
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis.
Linden T; Cohen A; Deppisch R; Kjellstrand P; Wieslander A
Kidney Int; 2002 Aug; 62(2):697-703. PubMed ID: 12110035
[TBL] [Abstract][Full Text] [Related]
7. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes.
Nilsson-Thorell CB; Muscalu N; Andrén AH; Kjellstrand PT; Wieslander AP
Perit Dial Int; 1993; 13(3):208-13. PubMed ID: 8369351
[TBL] [Abstract][Full Text] [Related]
8. PD fluids contain high concentrations of cytotoxic GDPs directly after sterilization.
Erixon M; Lindén T; Kjellstrand P; Carlsson O; Ernebrant M; Forsbäck G; Wieslander A; Jönsson JA
Perit Dial Int; 2004; 24(4):392-8. PubMed ID: 15335155
[TBL] [Abstract][Full Text] [Related]
9. A commercially available PD fluid with high pH and low GDP induces different morphological changes of rat peritoneum in intermittent PD.
Jonasson P; Braide M
Adv Perit Dial; 1998; 14():48-53. PubMed ID: 10649690
[TBL] [Abstract][Full Text] [Related]
10. Glucose degradation and cytotoxicity in PD fluids.
Wieslander A; Lindén T
Perit Dial Int; 1996; 16 Suppl 1():S114-8. PubMed ID: 8728175
[No Abstract] [Full Text] [Related]
11. Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis.
Tauer A; Bender TO; Fleischmann EH; Niwa T; Jörres A; Pischetsrieder M
Mol Nutr Food Res; 2005 Jul; 49(7):710-5. PubMed ID: 15915443
[TBL] [Abstract][Full Text] [Related]
12. Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.
Ishikawa N; Miyata T; Ueda Y; Inagi R; Izuhara Y; Yuzawa H; Onogi H; Nishina M; Nangaku M; Van Ypersele De Strihou C; Kurokawa K
Kidney Int; 2003 Jan; 63(1):331-9. PubMed ID: 12472800
[TBL] [Abstract][Full Text] [Related]
13. Take care in how you store your PD fluids: actual temperature determines the balance between reactive and non-reactive GDPs.
Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
Perit Dial Int; 2005; 25(6):583-90. PubMed ID: 16411526
[TBL] [Abstract][Full Text] [Related]
14. Midpeliq reduces glucose load.
Itami N; Tsuji Y; Katsuki Y; Ohira S
Adv Perit Dial; 2003; 19():236-9. PubMed ID: 14763070
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts.
Kristensen SR; Pedersen FB
Nephrol Dial Transplant; 1993; 8(2):163-7. PubMed ID: 8384339
[TBL] [Abstract][Full Text] [Related]
16. Structure- and concentration-specific assessment of the physiological reactivity of α-dicarbonyl glucose degradation products in peritoneal dialysis fluids.
Distler L; Georgieva A; Kenkel I; Huppert J; Pischetsrieder M
Chem Res Toxicol; 2014 Aug; 27(8):1421-30. PubMed ID: 25033248
[TBL] [Abstract][Full Text] [Related]
17. Less infusion pain and elevated level of cancer antigen 125 by the use of a new and more biocompatible PD fluid.
Simonsen O; Wieslander A; Landgren C; Rippe B
Adv Perit Dial; 1996; 12():156-60. PubMed ID: 8865892
[TBL] [Abstract][Full Text] [Related]
18. Reducing the formation of glucose degradation products in peritoneal dialysis solutions by ultrahigh temperature ohmic heating.
Shapira A; Shazman A; Ungar Y; Shimoni E
Mol Nutr Food Res; 2007 Apr; 51(4):473-8. PubMed ID: 17390399
[TBL] [Abstract][Full Text] [Related]
19. Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells.
Linden T; Musi B; Järkelid L; Forsbäck G; Kjellstrand P; Deppisch R; Wieslander A
Perit Dial Int; 2001; 21(6):607-10. PubMed ID: 11783771
[TBL] [Abstract][Full Text] [Related]
20. How to avoid glucose degradation products in peritoneal dialysis fluids.
Erixon M; Wieslander A; Lindén T; Carlsson O; Forsbäck G; Svensson E; Jönsson JA; Kjellstrand P
Perit Dial Int; 2006; 26(4):490-7. PubMed ID: 16881345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
